Subcutaneous injection
Coming soonComing soon
Prescription strengthLabeled vial
Concentration, syringe units, days of supply, storage, and refill timing will be listed before ordering.
Coming soon
BPC-157
Studied for inflammation and tissue repair.
In animal research, BPC-157 has improved measures of tendon and ligament healing and shown anti-inflammatory activity across muscle, wound, arthritis, and gastrointestinal injury models. Human studies are still too limited to know how reliably those results carry over.
Be first to know when orders open.
Product updates and occasional emails. Unsubscribe anytime.
Animalrepair research
Injectionsubcutaneous format
Coming soonjoin the interest list
Before you order
See the vial, dose, pharmacy, and price.
Every prescription should show the formulation, concentration, syringe units, days of supply, storage, refill timing, pharmacy, and price.
U.S. pharmacy fulfillment
Coming soonComing soon
Licensed compounding pharmacyShipped to your door
The dispensing pharmacy, formulation, source documentation, storage, and beyond-use date will accompany the prescription.
- Format
- Subcutaneous injection
- Pharmacy
- Licensed U.S. compounding pharmacy
- Supply
- Listed before ordering
- Availability
- Coming soon
What researchers have studied
Inflammation. Tendons. Ligaments. Muscle. Gut.
Inflammation
Animal and laboratory studies have reported reduced inflammatory activity across muscle, wound, and gastrointestinal injury models.
Tendon and ligament repair
Rat studies reported better functional, biomechanical, microscopic, and tissue-healing measures after Achilles tendon and ligament injury.
Muscle, wound, and gut repair
BPC-157 has also been studied across muscle, wound, blood-vessel, and gastrointestinal repair models—one reason the recovery interest is so broad.
Preclinical tendon and ligament repair
Disrupted fibers. New vessels. A stronger repair bridge.
In rat tendon, ligament, and myotendinous injury models, BPC-157 was associated with reduced inflammatory activity, new vascular growth, more organized collagen, and better functional and biomechanical healing measures. Human recovery trials have yet to establish the same effects.
01Acute injuryDisrupted collagen and inflammatory activity
02Repair phaseVascular growth and bridging fibers
03Organized tissueDenser, aligned ligament in animal models
Laboratory and animal workPreclinical
Inflammation and repair signals
Animal and laboratory studies have reported anti-inflammatory activity and explored tendon, ligament, muscle, wound, blood-vessel, and gastrointestinal repair. That breadth explains the interest.
Human evidenceLimited
The human evidence gap
Current human evidence is too limited to establish faster tendon healing, less pain, or a standard recovery result from a compounded subcutaneous BPC-157 product.
Prescription detailsBefore ordering
What is actually in the vial
Free base and acetate are different substances. The label should identify the formulation, concentration, storage, and beyond-use date for the vial dispensed.
BPC-157 by the numbers
A small peptide with a wide preclinical footprint.
These numbers describe the molecule and the design of published animal studies.
15
amino acids
BPC-157 is a pentadecapeptide: a short chain with the published sequence below and a molecular weight of 1,419.
GEPPPGKPADDAGLV
5checkpoints
14days
A rat Achilles-tendon study assessed function daily and examined biomechanics, microscopy, and visible tissue repair at five points.
01Day 1
02Day 4
03Day 7
04Day 10
05Day 14
4
ways repair was measured
In a rat medial-collateral-ligament model, researchers followed healing through 90 days and reported improvement across four domains.
01FunctionHow the injured limb moved
02BiomechanicsHow much load the tissue handled
03MicroscopyHow cells and collagen reorganized
04Tissue integrityHow the visible defect closed
90days of follow-up
in the rat ligament study
in the rat ligament study
Preclinical evidence only. Study models, routes, doses, and endpoints do not establish a predictable benefit for a compounded human prescription.
What comes with the prescription
Clear details from the vial through the refill.
The formulation
See the exact BPC-157 substance, concentration, vial size, storage requirements, and beyond-use date.
The pharmacy
See the licensed U.S. compounding pharmacy filling the prescription and the states it serves.
The directions
Your label connects the vial concentration to syringe units, timing, quantity, missed-dose instructions, and refills.
Refill help
Message the care team about injection irritation, travel, storage, missed doses, new symptoms, or refills.
Coming soon
Orders are closed.
Join the interest list for availability, price, pharmacy, strength, supply, and states served. A compounded BPC-157 product would not be FDA-approved.
See launch details